ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,959Medicare Part D Prescriptions Filled, Including Refills

Rank: 258 out of 939

$410K Total Retail Price of All Prescriptions

Rank: 349 out of 939

354 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

27% of this provider’s 354 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

0% of this provider’s 7,658 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
AMLODIPINE BESYLATE 611 503 1 6
HYDROCODONE-ACETAMINOPHEN 517 322 S3 2 1
PRAVASTATIN SODIUM 398 325 3 13
LISINOPRIL 351 299 4 3
WARFARIN SODIUM 339 300 5 17
CARVEDILOL 320 277 6 25
METOPROLOL TARTRATE 278 216 7 10
OMEPRAZOLE 271 207 8 5
GABAPENTIN 259 172 9 11
CITALOPRAM HBR 250 196 10 15
LEVOTHYROXINE SODIUM 249 189 11 4
LOSARTAN POTASSIUM 237 216 12 29
POTASSIUM CHLORIDE 230 183 13 9
FUROSEMIDE 214 183 14 7
RANITIDINE HCL 183 160 15 35
GLIMEPIRIDE 181 129 16 37
SERTRALINE HCL 179 162 17 24
TRAZODONE HCL 174 129 18 26
ZOLPIDEM TARTRATE 117 87 19 20
MIRTAZAPINE 116 112 20 56
FLUTICASONE PROPIONATE 105 81 21 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 87 21 23
METFORMIN HCL 104 82 23 8
LOSARTAN-HYDROCHLOROTHIAZIDE 103 64 24 55
CEFDINIR 102 80 25 142
HYDROCHLOROTHIAZIDE 98 83 26 12
TRAMADOL HCL 93 77 27 16
NEXIUM 90 58 28 18
ALENDRONATE SODIUM 75 75 29 40
PANTOPRAZOLE SODIUM 72 41 30 66
ATORVASTATIN CALCIUM 71 46 31 22
SIMVASTATIN 65 61 32 2
ISOSORBIDE MONONITRATE ER 64 52 33 53
COMBIVENT 63 25 34 120
TRIAMTERENE-HCTZ 62 45 35 33
BENAZEPRIL HCL 61 57 36 87
VENLAFAXINE HCL ER 60 47 37 121
CRESTOR 58 57 38 34
LEVOFLOXACIN 56 47 39 86
AGGRENOX 54 44 40 153
SYMBICORT 53 36 41 137
DIOVAN 51 37 42 50
PREDNISONE 50 45 43 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 14, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.